J&J/Innovasive
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson has paid Innovasive Devices stockholders a total of $85 mil. for 100% ownership of the sports medicine device manufacturer, the firm announces Feb. 11. The selling price represents an exchange rate of 0.0948 J&J shares of for each share of Innovasive stock. The total price is $2 mil. higher than reported in November when the deal was announced (1"The Gray Sheet" Nov. 15, p. 12)
You may also be interested in...
J&J Adds To Sports Medicine Line With $83 mil. Innovasive Devices Buy
Johnson & Johnson's $83 mil. acquisition of Innovasive Devices, a maker of minimally invasive arthroscopic surgery devices, adds breadth to the company's sports medicine product line, which was initially established through earlier acquisitions of Mitek Surgical and OrthoTech.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.